Dr Amneet Kaur Hans, MD - Medicare Gastroenterology in Dallas, TX

Dr Amneet Kaur Hans, MD is a medicare enrolled "Internal Medicine - Gastroenterology" physician in Dallas, Texas. She graduated from medical school in 2016 and has 8 years of diverse experience with area of expertise as Gastroenterology. She is a member of the group practice Healthtexas Provider Network and her current practice location is 3409 Worth St Ste 600, Dallas, Texas. You can reach out to her office (for appointments etc.) via phone at (469) 800-7180.

Dr Amneet Kaur Hans is licensed to practice in Texas (license number U4211) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1255794475.

Contact Information

Dr Amneet Kaur Hans, MD
3409 Worth St Ste 600,
Dallas, TX 75246-2042
(469) 800-7180
Not Available



Physician's Profile

Full NameDr Amneet Kaur Hans
GenderFemale
SpecialityGastroenterology
Experience8 Years
Location3409 Worth St Ste 600, Dallas, Texas
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Amneet Kaur Hans graduated from medical school in 2016
  NPI Data:
  • NPI Number: 1255794475
  • Provider Enumeration Date: 04/04/2016
  • Last Update Date: 09/28/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 0143512020
  • Enrollment ID: I20230822001285

Medical Identifiers

Medical identifiers for Dr Amneet Kaur Hans such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1255794475NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RG0100XInternal Medicine - Gastroenterology 315317 (New York)Secondary
207RG0100XInternal Medicine - Gastroenterology U4211 (Texas)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Baylor University Medical CenterDallas, TXHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Healthtexas Provider Network13552542101810

News Archive

Lengthy treatment with low-dose 6-mercaptopurine inhibits resistant triple-negative breast cancer cells

The cover for issue 7 of Oncotarget features Figure 5, "SUM149-MA cells surviving a 6-MP treatment are sensitive to chemotherapeutic drugs," published in "Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine" by Singh, et al. which reported that the authors have reported that a lengthy treatment with low-dose 6-mercaptopurine, a clinically useful anti-inflammatory drug, inhibits such resistant cells.

Clinical trial results of Genous Bio-engineered R stent, EPC capture technology presented at TCT 2010

OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.

Protein kinase inhibitors could help treat immunodeficiency in HIV patients

HIV infections are treated with antiviral drugs which effectively prevent the disease from developing. While pharmacological HIV therapy has advanced considerably, the virus cannot be entirely eliminated from the body with currently available drugs.

TSRI scientists reveal how mutations in specific autism risk gene alter pattern of early brain development

As early as 1943, when autism was first described by psychiatrist Leo Kanner, reports were made that some, but not all, children with autism spectrum disorder have relatively enlarged heads. But even today, more than half a century later, the exact cause of this early abnormal growth of the head and brain has remained unclear.

Screening colonoscopy program brings down colorectal cancer rates in Germany

The introduction of screening colonoscopy in Germany is showing results: Within ten years of the start of this screening program for the early detection of colorectal cancer, the number of new cases has significantly dropped in the age groups 55 years and over.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Amneet Kaur Hans allows following entities to bill medicare on her behalf.
Entity NameHealthtexas Provider Network
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1760488936
PECOS PAC ID: 1355254210
Enrollment ID: O20040727001187

News Archive

Lengthy treatment with low-dose 6-mercaptopurine inhibits resistant triple-negative breast cancer cells

The cover for issue 7 of Oncotarget features Figure 5, "SUM149-MA cells surviving a 6-MP treatment are sensitive to chemotherapeutic drugs," published in "Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine" by Singh, et al. which reported that the authors have reported that a lengthy treatment with low-dose 6-mercaptopurine, a clinically useful anti-inflammatory drug, inhibits such resistant cells.

Clinical trial results of Genous Bio-engineered R stent, EPC capture technology presented at TCT 2010

OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.

Protein kinase inhibitors could help treat immunodeficiency in HIV patients

HIV infections are treated with antiviral drugs which effectively prevent the disease from developing. While pharmacological HIV therapy has advanced considerably, the virus cannot be entirely eliminated from the body with currently available drugs.

TSRI scientists reveal how mutations in specific autism risk gene alter pattern of early brain development

As early as 1943, when autism was first described by psychiatrist Leo Kanner, reports were made that some, but not all, children with autism spectrum disorder have relatively enlarged heads. But even today, more than half a century later, the exact cause of this early abnormal growth of the head and brain has remained unclear.

Screening colonoscopy program brings down colorectal cancer rates in Germany

The introduction of screening colonoscopy in Germany is showing results: Within ten years of the start of this screening program for the early detection of colorectal cancer, the number of new cases has significantly dropped in the age groups 55 years and over.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Amneet Kaur Hans is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Amneet Kaur Hans, MD
3409 Worth St Ste 600,
Dallas, TX 75246-2042

Ph: () -
Dr Amneet Kaur Hans, MD
3409 Worth St Ste 600,
Dallas, TX 75246-2042

Ph: (469) 800-7180

News Archive

Lengthy treatment with low-dose 6-mercaptopurine inhibits resistant triple-negative breast cancer cells

The cover for issue 7 of Oncotarget features Figure 5, "SUM149-MA cells surviving a 6-MP treatment are sensitive to chemotherapeutic drugs," published in "Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine" by Singh, et al. which reported that the authors have reported that a lengthy treatment with low-dose 6-mercaptopurine, a clinically useful anti-inflammatory drug, inhibits such resistant cells.

Clinical trial results of Genous Bio-engineered R stent, EPC capture technology presented at TCT 2010

OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture Technology: from Genous to Combo" at Transcatheter Cardiovascular Therapeutics 2010 in Washington.

Protein kinase inhibitors could help treat immunodeficiency in HIV patients

HIV infections are treated with antiviral drugs which effectively prevent the disease from developing. While pharmacological HIV therapy has advanced considerably, the virus cannot be entirely eliminated from the body with currently available drugs.

TSRI scientists reveal how mutations in specific autism risk gene alter pattern of early brain development

As early as 1943, when autism was first described by psychiatrist Leo Kanner, reports were made that some, but not all, children with autism spectrum disorder have relatively enlarged heads. But even today, more than half a century later, the exact cause of this early abnormal growth of the head and brain has remained unclear.

Screening colonoscopy program brings down colorectal cancer rates in Germany

The introduction of screening colonoscopy in Germany is showing results: Within ten years of the start of this screening program for the early detection of colorectal cancer, the number of new cases has significantly dropped in the age groups 55 years and over.

Read more News

› Verified 2 days ago


Internal Medicine Doctors in Dallas, TX

Uma B.r.k Pakkivenkata, M.D.
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: 9900 N Central Expy Ste 215, Dallas, TX 75231
Phone: 214-396-4950    Fax: 877-423-5360
Dr. Ariel Marcelo Modrykamien, M.D.
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: 3600 Gaston Ave, Wadley Tower, Suite 960, Dallas, TX 75246
Phone: 402-972-6078    
Benjamin Seth Martinez, MD
Gastroenterology
Medicare: Not Enrolled in Medicare
Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390
Phone: 214-648-3111    Fax: 214-648-5461
Vijaya Mummadi, M.D.
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: 9900 N Central Expy Ste 225, Dallas, TX 75231
Phone: 469-646-8880    Fax: 469-646-8884
Dr. Ting-yi Chen, M.D.
Gastroenterology
Medicare: Not Enrolled in Medicare
Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390
Phone: 214-645-2800    Fax: 214-645-2808
William Cook Langmade, MD
Gastroenterology
Medicare: Medicare Enrolled
Practice Location: 1441 N Beckley Ave, Dallas, TX 75203
Phone: 214-947-2306    
Dr. Janame J Kottey, MBBS
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: 13154 Coit Rd Ste 100, Dallas, TX 75240
Phone: 214-358-2300    Fax: 214-579-6989

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.